Caffeine Completed Phase 2 Trials for Parkinson's Disease (PD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01190735Caffeine for Motor Manifestations of Parkinson's Disease